Dr. Reddy`s Laboratories Profit Margin

Dr. Reddy`s Laboratories (RDY) currently reports a profit margin of 8.46% as of September 2026. That compares with 17.13% in the prior-year period — down 50.6% year over year. That is below the Healthcare sector average of 17.63%. Use the charts on this page to explore Dr. Reddy`s Laboratories's profit margin history and peer comparisons.

Dr. Reddy`s Laboratories's profit margin decreased from 17.13% to 8.46% — a 50.6% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Dr. Reddy`s Laboratories's profit margin of 8.46% is lower than the Healthcare sector average of 17.63%. That is roughly 52.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Dr. Reddy`s Laboratories's current 8.46% should be judged against Healthcare norms (sector average: 17.63%) and against RDY's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 8.46%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 17.63%. From there, open related valuation or income-statement pages for Dr. Reddy`s Laboratories, and consider following RDY for alerts when major investors trade the stock.